Trials / Unknown
UnknownNCT00351494
Myoma Microvascularization Analysis Using Sonovue Before and After Uterine Artery Embolization
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- University Hospital, Tours · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Contrast-enhanced ultrasound is supposed to improve the detection of myomas as well as improve the follow-up after specific treatments like embolization. It will also help the investigators better understand the mechanism of success or failure for embolization and could reduce the amount of particles injected by determining the endpoint of the procedure in order to treat the myomas while preserving the myometrium.
Detailed description
Before embolization of the uterine artery, 40 patients with unique or multiple myomas will be included prospectively in our study and evaluated with sonography before and after injection of Sonovue (2.4 ml) (Bracco Int Milano Italy). Pelvic ultrasound with contrast enhancement will be done the day after and six months after the procedure. Microvascularization of the myomas and the endometrium will be described. Some tiny myomas which are not visible on conventional sonography could be identified for a perfect matching with MRI detection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | contrast enhanced ultrasonography | Three contrast-enhanced ultrasonography : before embolization, after one day and after 6 months. Abdominal route 2.4 ml sonovue per injection / bolus |
| PROCEDURE | embolization | Intervention is described in the case report form for each patient |
Timeline
- Start date
- 2006-07-01
- Completion
- 2009-06-01
- First posted
- 2006-07-13
- Last updated
- 2007-11-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00351494. Inclusion in this directory is not an endorsement.